...
首页> 外文期刊>The Biochemical Journal >Ufd1 phosphorylation at serine 229 negatively regulates endoplasmic reticulum-associated degradation by inhibiting the interaction of Ufd1 with VCP
【24h】

Ufd1 phosphorylation at serine 229 negatively regulates endoplasmic reticulum-associated degradation by inhibiting the interaction of Ufd1 with VCP

机译:丝氨酸229的UFD1磷酸化通过抑制UFD1与VCP的相互作用来负调节内质网相关的降解

获取原文
获取原文并翻译 | 示例

摘要

Misfolded proteins in the endoplasmic reticulum (ER) are removed through multistep processes termed ER-associated degradation (ERAD). Valosin-containing protein (VCP) plays a crucial role in ERAD as the interaction of ubiquitin fusion degradation protein 1 (Ufd1) with VCP via its SHP box motif (F-228-S-G-S-G-N-R-L-235) is required for ERAD. However, the mechanisms by which the VCP-Ufd1 interaction is regulated are not well understood. Here, we found that the serine 229 residue located in the Ufd1 SHP box is phosphorylated in vitro and in vivo by cyclic adenosine monophosphate-dependent protein kinase A (PKA), with this process being enhanced by either forskolin (an adenylyl cyclase activator) or calyculin A (a protein phosphatase inhibitor). Moreover, a phosphomimetic mutant (S229D) of Ufd1 as well as treatment by forskolin, calyculin A, or activated PKA strongly reduced Ufd1 binding affinity for VCP. Consistent with this, the Ufd1 S229D mutant significantly inhibited ERAD leading to the accumulation of ERAD substrates such as a tyrosinase mutant (C89R) and 3-hydroxy-3-methylglutaryl coenzyme A reductase. However, a non-phosphorylatable Ufd1 mutant (S229A) retained VCP-binding ability and was less effective in blocking ERAD. Collectively, our results support that Ufd1 S229 phosphorylation status mediated by PKA serves as a key regulatory point for the VCP-Ufd1 interaction and functional ERAD.
机译:通过MultiSep工艺除去内质网(ER)中的错误折叠蛋白质被称为ER相关的降解(ERAD)。含缬氨酸的蛋白质(VCP)在ERAD中作为泛素融合降解蛋白1(UFD1)与VCP的相互作用进行了相互作用,ERAD需要与VCP(F-228-S-G-S-G-N-R-335)。然而,监管VCP-UFD1相互作用的机制也不太了解。在此发现,位于UFD1 SHP盒中的丝氨酸229残基通过环状腺苷依赖于依赖性蛋白激酶A(PKA)在体外和体内磷酸化,通过Forskolin(Adenylyl环酶激活剂)或Calyculin a(蛋白质磷酸酶抑制剂)。此外,UFD1的磷酸突变体(S229D)以及通过Forskolin,Calyculin A或活化的PKa处理的磷酸突变体(S229D)强烈降低了对VCP的UFD1结合亲和力。符合此,UFD1 S229D突变体显着抑制了ERAD,导致ERAD底物(如酪氨酸酶突变体(C89R)和3-羟基-3-甲基戊族辅酶A还原酶的积累。然而,不磷酸化的UFD1突变体(S229A)保留了VCP结合能力,并且在阻塞ERAD方面不太有效。统称,我们的结果支持PKA介导的UFD1 S229磷酸化状态用作VCP-UFD1相互作用和功能Erad的关键调节点。

著录项

  • 来源
    《The Biochemical Journal 》 |2019年第18期| 共17页
  • 作者单位

    Ajou Univ Grad Sch Med Chron Inflammatory Dis Res Ctr Dept Biomed Sci Neurosci Grad Program Suwon 16499 Gyeonggi South Korea;

    Ajou Univ Grad Sch Med Chron Inflammatory Dis Res Ctr Dept Biomed Sci Neurosci Grad Program Suwon 16499 Gyeonggi South Korea;

    Soongsil Univ Coll Nat Sci Dept Chem Seoul 06978 South Korea;

    Ajou Univ Grad Sch Med Chron Inflammatory Dis Res Ctr Dept Biomed Sci Neurosci Grad Program Suwon 16499 Gyeonggi South Korea;

  • 收录信息
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类 生物化学 ;
  • 关键词

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号